Manufacturer network
Long, quiet
partnerships.
Our partners include European specialty manufacturers and global generic players — each with multi-year distribution agreements across the Balkans and the EU. We measure ourselves by the number of partners who renew.
Strategic partners
Cardiovascular · Diabetes
Hemofarm
Since 2018
Generics · All TAs
Stada
Since 2017
Biosimilars · Specialty
Sandoz
Since 2019
CNS · Respiratory
Alpen Pharma
Since 2016
Oncology · Rare disease
Novartis
Since 2021
Vaccines · Specialty
GSK
Since 2022
Active partners
Generics · Injectables
PharmaSwiss
Since 2020
OTC · Consumer health
Berlin-Chemie
Since 2021
CNS · Cardiology
KRKA
Since 2020
Respiratory
Lupin
Since 2023
Hospital · Injectables
Hikma
Since 2022
Ophthalmology
Thea Pharma
Since 2023
Project partners
Specialty · Orphan
Swedish Orphan Biovitrum
Since 2024
Dermatology
Galderma
Since 2024
Women's health
Gedeon Richter
Since 2023
Hospital · Diagnostics
Roche Diagnostics
Since 2022
Hospital · Contrast media
Guerbet
Since 2024
Vaccines · Travel health
Sanofi Pasteur
Since 2024
What our partners say
Words from the
manufacturer's table.
Three of our long-term partners describe what makes the AMDIS relationship different — in their own words.
"AMDIS runs our Balkans operations with the discipline of an internal country organisation. Their QPs are exacting, their reporting is honest, and they surface problems before we do."Regional Director, SEEMid-cap European specialty manufacturer
"We compared AMDIS with three larger distributors before signing. Three years later, they handle 60% of our regional volume. We never looked back."Head of ExportGeneric manufacturer, Slovenia
Become a partner
Evaluating AMDIS
for your molecule?
We respond to qualified manufacturer inquiries within two business days. A short call is the fastest way to understand whether the partnership makes sense for both sides.